Clinical embryology has put into practice in the laboratories for assisted reproduction techniques (ART) the recent discoveries regarding the physiology of early events in the development of human life. The embryologist is responsible for the correct and justified application of ART in these laboratories.
1. Staffing and direction 1.1. The laboratory is directed by an appropriately qualified and experienced scientist or medical doctor according to national rules.
1.2.
There are appropriate numbers of staff with the required experience to undertake the workload of the laboratory.
1.3.
All new staff are given a comprehensive orientation and introduction programme.
1.4.
Continuing medical education (CME) is recommended for all personnel involved.
1.5.
Individual responsibility of each member of staff and line of responsibilities are indicated in a written procedure.
Policies and procedures
2.1. All laboratory procedures must include provision for unique patient identification whilst retaining patient confidentiality.
2.2.
Laboratory results should be reported according to a written procedure. They should be validated, dated and include unique patient identity. Any interpretation of results should be accurate, comprehensive and clinically relevant.
2.3.
There is a record of all reagents, calibration and quality control material.
2.4.
There is a written, signed and dated protocol for every procedure, written transmission of results and regular maintenance of equipment. w w w . s h i v a n i s c i e n t i f i c . c o m
When commissioning the laboratory, thought should be given to the most recent developments in equipment and facilities. Bench height, adjustable chairs, microscope eye height, efficient use of space and surfaces, sufficient air-condition and the amount of daylight, all contribute to a working environment that minimizes distraction and fatigue. Consideration should also be given to local health and safety requirements.
Laboratory equipment
• The laboratory equipment used should be adequate for laboratory work and easy to clean and disinfect.
• Critical items of equipment, including incubators and frozen embryo storage facilities, should be appropriately alarmed and monitored.
• All embryo laboratories should have an automatic emergency generator backup in the event of power failure.
• A minimum number of two incubators is recommended. Gas cylinders should be placed outside or in a separate room with an automatic backup system. • Incubators should be frequently cleaned and sterilized. Nitrogen tanks should be cleaned and sanitized at least every year.
Infectious agents
All assisted reproductive technologies involve handling biological material, and pose a potential hazard of transmitting diseases to personnel. Sources of infection in this system are compounds and follicle fluid of animal origin. Each unit should establish procedures and policies for the safety of personnel, taking national and/or local safety regulations into consideration. Therefore:
• Vaccination of the personnel against hepatitis B or other available viral disease is recommended.
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• Screening patients and gamete donors for HIV, hepatitis B/C and other sexually transmitted diseases before treatment or gamete cryopreservation should be routinely adopted.
Although patients' admittance to IVF treatment cycles is regulated by physicians, the laboratory staff must be informed about the risks of handling potentially infected biological material. The following recommendations should be considered:
• If one or both partners are HIV-positive, IVF and embryo transfer should not be attempted, unless local rules give authorization after extensive examination. Donor semen is advised for a seronegative woman if her partner is seropositive, as HIV-1 viral particles may be present in the cytoplasmic compartment of motile spermatozoa (Baccetti et al., 1994 ) . Therefore, the possibility exists that viral particles enter the oocyte during fertilization either with conventional IVF or intracytoplasmic sperm injection (ICSI). The fate of these particles in the resulting embryo is unknown.
• If the male partner is infected by the virus of hepatitis B, the seronegative woman must be vaccinated before IVF.
• If the woman is infected by the virus of hepatitis B, IVF is feasible but the couple must be warned about the necessity of specific vaccination of the baby at birth. It has been recently suggested that the use of ICSI in hepatitis B-positive patients could increase the risk of bringing the virus into the oocyte from the surrounding fluid, possibly adhered to the sperm membrane.
• If one partner is infected by the virus of hepatitis C, IVF may be performed after extensive counselling.
• In case of seropositivity for syphilis, appropriate treatment must be given before IVF.
Protective measures
The purpose of the protective measures is also to ensure aseptic conditions for gamete and embryos. The procedures should deal with, but not be limited to, the following:
• Use of laboratory clothing.
• Use of non-toxic (non-powdered) gloves and masks.
• Use of eye and face protection if cryogenic materials are handled.
• Use of vertical laminar-flow benches.
• Use of mechanical pipetting devices.
• Use of fume-hood in case of fixatives.
• Disinfection and sterilization of potentially infected equipment.
• Use of disposable material; after usage, it must be discarded immediately in the proper waste containers. Potential infectious materials must be disposed of in a manner that protects laboratory workers and maintenance, service, and housekeeping staff from exposure to infectious materials in the course of their work.
• Needles and other sharps should be handled with extreme caution and discarded in special containers. If possible, glassware should be omitted in the laboratory, otherwise the Pasteur pipettes and broken glassware should be discarded in special containers.
Cross-contamination with infectious material from one patient to another could still occur during the cryopreservation procedure when straws with semen or embryos are filled by dipping the w w w . s h i v a n i s c i e n t i f i c . c o m straw in patient medium with semen or embryos, sealing it and passing it into liquid nitrogen without external disinfection (Tedder et al., 1995 ) . Material stored in the cryopreservation tanks should be kept in a way that avoids contact of the liquid nitrogen phase with the biological substances. Safety cryo straws have been conceived in order to fulfil this requirement. Specimen known to be contaminated should be stored in such high security straws.
Correct handling and identification of patients and their gametes and embryos
Written procedures should be present describing the various phases of IVF techniques. Rules concerning the correct handling and identification of gametes and embryo samples should be established by a system of checks and, where needed, double-checks. Proper training of all the laboratory staff according to these procedures is mandatory.
• All material obtained from the patients, i.e. tubes with blood, follicular fluid and spermatozoa, should bear unique identification of the treated couple.
• Incubators should be organized in order to facilitate identification of embryos, oocytes and spermatozoa.
• Verification of patients' identity should be performed at critical steps: before ovum retrieval, at semen recovery and embryo transfer procedures.
• Double checks need to be considered at least at: insemination of oocytes, replacement of embryos, embryo freezing and thawing.
Written validation of all critical steps in each patient's file is essential.
Culture media preparation and quality control testing

Disposables and reagents.
• Glassware and disposable items used for preparation of culture media should be of tissue culture grade and dedicated for this purpose alone.
• Culture media, or reagents used in their preparation, should be of a purity appropriate for the purpose.
5.2. Laboratory protocols should include in-house quality control procedures for culture media.
• All tissue culture media prepared in the laboratory should undergo quality control using an appropriate bioassay system. • When commercially produced media are used, integrity of the packages and appropriate delivery conditions should be controlled.
• Documentation of quality control testing should be supplied by the manufacturer for any commercially produced media employed. Correspondence with the delivered batch should be verified.
• Reagents and media should always be used prior to the manufacturer's expiry date.
Water used for the preparation of culture media should be of appropriate purity.
• If the water is purified on site, protocols must be in place for quality control of the water system, including sanitization of the system, regular cartridge changes and replacement of other components, endotoxin and bacterial screening. w w w . s h i v a n i s c i e n t i f i c . c o m
• If culture grade water is purchased there must be strict control over storage and use in relation to temperature and shelf-life.
There should be a systematic record of all batch numbers of reagents, media and disposables used in the preparation of media with the date of their introduction to the system.
• Reagents should be designated exclusively for use in culture media.
Donor serum or follicular fluid are not recommended.
If they are used in culture media they should be screened according to the local rules for blood donors.
• Human serum albumin (HSA) should come from a source screened as above. Commercial suppliers of HSA or media containing a serum derived protein source should supply evidence of such screening.
• Appropriate quarantining arrangements should be in place for donor use.
Oocytes may be cultured under equilibrated mineral oil.
The oil maintains temperature, osmotic pressure and pH during short-term manipulations of the oocytes. Before use, it requires pre-equilibration in the incubator.
Handling of oocytes and spermatozoa
The laboratory procedures regarding the handling of gametes for assisted reproduction techniques have been standardized to a large extent. The procedures should be easy, simple and effective and must be performed in a laminar flow hood equipped with stages and heating blocks pre-warmed at 37°C. Class II hoods should be preferred as they give protection to the operator. Disposable items used in the laboratory preparation of culture media should be of tissue culture grade.
Aseptic technique should be used at all times.
6.2. Appropriate measures should be taken to ensure that oocytes and embryos are maintained at 37°C during handling/observation using hot plates or other systems.
6.3.
Tissue culture grade disposables should be used for handling body fluids/cells.
6.4.
Pipetting devices (pasteurs, drawn pipettes, tips etc.) should be used for one procedure only, should never be used for more than one patient, and should be disposed of immediately after use. 6.5. Simultaneous treatment of more than one patient should never be done in the same working place.
6.6. Identifying information marked on the culture dish/tube should be cross-referenced to the patient and the patient's documentation.
• Procedures should be in place which ensure correct patient identification at all stages. w w w . s h i v a n i s c i e n t i f i c . c o m
• Labelling of dishes/tubes containing oocytes, embryos, or spermatozoa should be permanent. (Strong odour markers should be avoided.) • Incubators should be organized in order to facilitate identification of embryos, oocytes and spermatozoa.
6.7.
At each stage of the procedure the identity of the embryologist should be recorded.
7. Oocyte retrieval 7.1. Oocytes need to be kept at body temperature (36-37°C) as much as possible. There should also be appropriate equipment in use to maintain this temperature when laboratory and egg collection areas are on different sites. Scanning Petri dishes, collection tubes and heating blocks are pre-warmed at 37°C. Follicular aspirates are checked for the presence of oocyte-cumulus complexes under a stereo dissecting microscope with transmitted illumination base and heated stage. Exposure of oocytes to light should be minimized where possible.
7.2.
Where donor oocytes are to be used they should be labelled with the donor's name, or reference code, at the time of oocyte retrieval, and only identified with the recipient's name at the time of allocation.
Sperm preparation
Before starting a treatment cycle, semen analysis is performed according to the protocols described in the World Health Organization manual (WHO, 1999) .
The semen sample is collected in a sterile, plastic container without using condoms, creams or lubricants. The container should be clearly labelled with the name of the couple.
8.1.
Records should be kept of the period of abstinence, the type of container used (if this differs from the norm), time and place of collection (with particular reference to samples produced outside clinic facilities), and the time interval between collection and preparation.
8.2.
Where donor spermatozoa is used, the necessary identifying information (donor code/clinic code) must be recorded.
8.3.
The method of sperm preparation should be recorded, including details of any variation on the standard laboratory protocol.
8.4.
A record should be kept of pre-and post-preparation sperm parameters and of any dilution carried out prior to insemination.
8.5.
In case of surgically retrieved spermatozoa, exceeding spermatozoa after insemination should be cryopreserved for further assisted reproductive cycles; this will avoid repeated surgery.
Insemination of oocytes
9.1. Preparation of spermatozoa for insemination.
The method of preparation is designed according to individual samples. A trial preparation prior w w w . s h i v a n i s c i e n t i f i c . c o m to the treatment cycle may be advisable in order to choose the most adequate technique. Sperm preparation aims to:
• concentrate and select the active and motile spermatozoa;
• get rid of seminal plasma, debris and contaminants;
• select against abnormal forms.
A frozen backup sample may be requested for those patients who anticipate the possibility of collection difficulty.
Different methods have been proposed for sperm preparation. Among them, the swim-up technique and the discontinuous density-gradient centrifugation are the most used (Burkman et al., 1984 ; McClure et al., 1989 ; Van der Zwalmen et al., 1991) .
As a general rule excessive centrifugation should be avoided especially in oligospermic samples in order to avoid increasing the concentration of reactive oxygen species.
Since January 1997 the Percoll that was used in the discontinuous density-gradient centrifugation procedure has been prohibited for clinical purposes.
The preparation of spermatozoa retrieved by microsurgical operations requires specific protocols (Devroey et al., 1994 ; Silber et al., 1994 Silber et al., , 1995 Oates et al., 1997 ; Kupker et al., 1998 ) .
9.2.
A record should be kept of the time of insemination and the sperm concentration used. For conventional insemination, the number of spermatozoa must be high enough to yield the best fertilization rate without compromising embryo development.
9.3.
For the intracytoplasmic sperm injection (ICSI) procedure, it is important to select vital spermatozoa, as evaluated by their motility. Where only non-vital sperm cells are present in the ejaculate, the use of testicular spermatozoa may be proposed.
Preparation of oocytes for ICSI. Removal of cumulus-corona (CC) cells.
Oocytes are denuded from the surrounding cumulus and corona cells using an enzymatic procedure with hyaluronidase, followed by mechanical denudation using a pipette with an inner diameter of ±150 µm. Both the enzyme concentration and the duration of exposure to the enzyme should be limited (Van de Velde et al., 1998 ) . Care needs to be taken in order to avoid damage to the oocytes, which can result from too vigorous pipetting or from a pipette diameter which is too small. After rinsing several times in washing medium drops, the denuded oocytes are observed under the inverted microscope at x200 magnification and cultured until the time of injection.
9.5. The injection procedure.
During ICSI, the following points are important:
• the selection and immobilization of a viable sperm cell; w w w . s h i v a n i s c i e n t i f i c . c o m
